Monday, February 09, 2026

5 wks
FDA CRL halts AstraZeneca’s Saphnelo prefilled pen approval (5)
5 wks
Glyphosate safety concerns resurface after key study retraction (2)


In Detail Full day, Monday, February 09, 2026, Timezone: America/Chicago

AstraZeneca gets CRL for prefilled pen version of lupus drug Saphnelo / Endpoints

Anna Brown / endpoints - The FDA has handed AstraZeneca a complete response letter for the subcutaneous prefilled, self-injectable pen of Saphnelo for systemic lupus erythematosus (SLE), a month after the asset gained approval in Europe ...

#healthcare #pharmaceuticals #biotech #drugdevelopment #fda

Former AstraZeneca senior staff charged with illegal trade in China

4 wks / endpoints / Nicole DeFeudis

Moderna says FDA refuses its application for new mRNA flu vaccine

4 wks / medicalxpress

FDA approves pembrolizumab with paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

4 wks / oncodaily

FDA delays approval of AstraZeneca’s injectable lupus drug

5 wks / beckershospitalreview / Ella Jeffries

AstraZeneca gets CRL for prefilled pen version of lupus drug Saphnelo

5 wks / endpoints / Anna Brown

Monday, February 9, 2026, 12:21 am / permalink 18917 / 5 stories in 5 wks


Glyphosate: What Indigenous communities have suspected for years about the dangers of the herbicide / The Conversation

Charles Z. Levkoe, Canada Research Chair in Equitable and Sustainable Food Systems, Lakehead Univers / theconversation - The recent retraction of peer-reviewed research claiming glyphosate is safe confirms what Indigenous communities have said for years.

#publichealth #governmentpolicy #foodsafety

Glyphosate: What Indigenous communities have suspected for years about the dangers of the herbicide

5 wks / medicalxpress

Glyphosate: What Indigenous communities have suspected for years about the dangers of the herbicide

5 wks / theconversation / Charles Z. Levkoe, Canada Research Chair in Equitable and Sustainable Food Systems, Lakehead Univers

Monday, February 9, 2026, 12:21 am / permalink 18916 / 2 stories in 5 wks


StackHealth Time Machine



Outgoing Stories

HIMSS 2026 pushes real‑time data, cloud and interoperability playbook 14 stories in 16.5 hours

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma 3 stories in 17.5 hours

Vitamin D trial shows reduced long‑COVID risk but no severity benefit 2 stories in 19.5 hours

Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival 4 stories in 20.5 hours

FDA approves leucovorin for rare folate disorder despite autism hype 4 stories in 32.5 hours

HORMAD1 emerges as a potential target in triple‑negative breast cancer 4 stories in 45.5 hours

Alfasigma pays $300M to GSK for linerixibat rights, expanding liver-disease portfolio 2 stories in 48.5 hours

Roche’s hoped‑for breast cancer pill fails crucial first‑line trial 5 stories in 49.5 hours

Novo Nordisk and Hims bury the hatchet and carve a deal 3 stories in 54.5 hours

AI improves UK breast-screening detection by about 10% 5 stories in 54.5 hours


More StackHealth

Bluesky:


NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.